Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CTI BioPharma Corp. (CTIC)
NASDAQ:CTIC
Holding CTIC?
Track your performance easily
CTIC Stock Chart & Stats
Day’s Range$9.09 - $9.1
52-Week Range― - ―
Previous Close$9.09
Volume11.42M
Average Volume (3M)N/A
Market Cap
$1.20B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding131,880,176
10 Day Avg. Volume0
30 Day Avg. Volume2,268,136
Standard Deviation0.33
R-Squared0.02
Alpha0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)-47.84
Price to Sales (P/S)49.71
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$9.73Price Target Upside7.04% Upside
Rating ConsensusHold
Number of Analyst Covering7
CTI BioPharma News
PremiumPress Releases
Sobi to Acquire CTI BioPharma
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CTIC FAQ
What was CTI BioPharma Corp.’s price range in the past 12 months?
Currently, no data Available
What is CTI BioPharma Corp.’s market cap?
Currently, no data Available
When is CTI BioPharma Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were CTI BioPharma Corp.’s earnings last quarter?
Currently, no data Available
Is CTI BioPharma Corp. overvalued?
According to Wall Street analysts CTI BioPharma Corp.’s price is currently Undervalued.
Does CTI BioPharma Corp. pay dividends?
CTI BioPharma Corp. does not currently pay dividends.
What is CTI BioPharma Corp.’s EPS estimate?
CTI BioPharma Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CTI BioPharma Corp. have?
Currently, no data Available
What happened to CTI BioPharma Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of CTI BioPharma Corp.?
Among the largest hedge funds holding CTI BioPharma Corp.’s share is Perceptive Advisors LLC. It holds CTI BioPharma Corp.’s shares valued at N/A.
---
CTI BioPharma Stock Smart Score
Company Description
CTI BioPharma Corp.
CTI BioPharma Corp. operates as a biopharmaceutical company, which focuses on the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. Its products include PIXUVRI, Pacritinib, Tosedostat and Opaxio. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.
---
CTIC Stock 12 Month Forecast
Average Price Target
$9.73
▲(7.04% Upside)
Technical Analysis
---